A drug for advanced ovarian cancer has been approved for use in newly diagnosed patients in England, after a trial showed it could delay progression of the disease for three years. Up to 600 women with a hereditary type of the disease could benefit each year. Health bosses said olaparib had the potential to make… Read More: Ovarian cancer drug olaparib ‘can delay disease in newly diagnosed’ »
As we get older our eyesight becomes vulnerable to age-related macular degeneration (ARMD) and diabetic macular oedema (DMO). Both conditions will cause blindness if left untreated. Their main feature is the excessive growth of blood vessels which can leak in the eye which clouds vision. This is due to leakage of fluid from the abnormal… Read More: Dr Miriam Stoppard: New drug brings hope of slowing sight… »
(Reuters) – A federal judge on Monday dealt a blow to the Trump administration by striking down a new rule that would have forced pharmaceutical companies to include the wholesale prices of their drugs in television advertising. A pharmacist refills a container in a drug dispensing machine at the Rock Canyon pharmacy in Provo, Utah,… Read More: U.S. judge strikes down Trump administration rule requiring drug prices… »
Sen. Amy Klobuchar speaks at the first U.S. 2020 presidential election Democratic candidates debate in Miami, Florida, June 26, 2019. Mike Segar | Reuters Sen. Amy Klobuchar lambasted President Donald Trump‘s record on lowering prescription drug prices during Wednesday’ night’s Democratic primary debate, but an analysis from RX Savings Solutions shows the presidential candidate overstated… Read More: Debate fact check: Sen. Klobuchar overstates Trump’s lack of success… »